An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin
Sunny L. Sneed(Harvard University), Robert M. Anthony(Massachusetts General Hospital)
Cited by 13
Related Papers
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
|Science Translational Medicine|2017|654